Murad Clarifying Cream Cleanser: the full product and the neighboring toner reply

The manufacturer identifies Clarifying Cream Cleanser in a 5 fl oz presentation with SKU 15459. The newer label’s principal panel names the same cream cleanser in a 148 mL package. These details define the reviewed item more closely than a general Murad acne category or a neighboring cleanser card. Manufacturer identity. Newer package panel. The size match is a statement about these descriptions, not a conversion into personal use duration. It also does not make Clarifying Toner another part of the cleanser package. Keeping the full item name in view helps when the surrounding page discusses several related acne products.

The retained website price is not used here as a fresh transaction quote. Identity is already useful without an unverified present offer. The version-and-label guide explains why package naming remains its own part of the inquiry.

The manufacturer declares salicylic acid 0.5% and a complete base, while preserving a qualification about checking the package list. The newer posted inactive declaration matches the retained manufacturer list. That supports a whole-product account rather than a review built entirely around the salicylic highlight. Manufacturer declaration. Newer label ingredients.

The page’s encapsulation narrative is still a manufacturer explanation. It does not provide our measurement of the finished cleanser or the amount released from a bottle. The two-percent comparison supplies a broader reminder that an active figure does not settle the rest of the preparation.

The inactivated 2021 record describes a 200 mL cream and includes Retinol in its complete inactive declaration. The newer 2025 record describes a 148 mL package with a different base. Reporting Retinol as a current cleanser ingredient simply because it appears in the older record would erase a consequential version distinction. Inactivated older record. Newer list. Inactivation is also retained as a status of the older listed record. It is not a firsthand finding about every old bottle or a reason to infer the manufacture date of the newer one. The historical base remains readable evidence of that document, without becoming the present ingredient list.

The two labels answer a history question; they do not assign a version to a reader’s container. For another formula-list problem, the Kate Somerville gel review provides a separate comparison of record-reading questions.

The manufacturer’s consumer account names 45 participants over two weeks. Its reported results are 100% finding the product non-irritating, 98% finding skin calm and 85% finding skin soothed and soft. Those are subjective comfort statements from the named summary, not independent pore measurements. An immediate-results heading elsewhere does not remove the two-week qualification. Consumer-test context. A consumer report of calm or softness answers a different question from the label’s acne use. The percentages should therefore stay attached to the participants’ reported comfort, with neither the group nor the period removed. That distinction is useful even when the advertised findings sound reassuring.

The full protocol, recruitment record and complete report were not read. The published numbers therefore retain their group, period and consumer character rather than becoming a tolerability guarantee or a clinical comparison with another cleanser.

Immediately before the cleanser FAQ, the page explicitly names Clarifying Toner and assigns pore-appearance, pore-tightening and oil-production wording to that toner. The cleanser answer that follows is a different reply. The proximity of the paragraphs does not make the toner’s statement a result for Clarifying Cream Cleanser. Named toner and adjacent cleanser context.

This small boundary has a large effect on attribution. The Dermalogica review offers another product-specific reading question: which parts of an ingredient narrative belong to a finished item, and what evidence actually accompanies that description?

The newer SPL table codes the dosage form as SOLUTION, while its principal panel calls the item Cream Cleanser. The older record codes cream. These fields should be reported as they stand; a reviewer should not silently correct one from personal assumptions about texture. Older dosage record. Newer code and panel.

The practical limit is that no sensory comparison or package inspection was performed. A coded form, consumer-facing name and quantity are distinct pieces of information. The supply-term guide also keeps a stated quantity separate from an observed delivery.

FDA explains that an NDC number and directory inclusion do not establish approval or verification of the supplied information. The newer label remains useful for identity, active amount, cautions and base. It does not convert the consumer-comfort account or encapsulation description into an independently approved performance finding. FDA directory limits. Current label fields.

The open questions are specific: the actual package version, the full consumer-study account and the evidence behind any finished-cleanser release claim. The records support a clear description now, while those unexamined questions remain visible.